6818:HKEXChina Everbright Bank Co., Ltd. Class H Analysis
Data as of 2026-03-15 - not real-time
HK$3.26
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
China Everbright Bank (6818.HK) is trading at HK$3.26, comfortably below its 20‑day (3.322) and 50‑day (3.363) SMAs and approaching the identified support level of HK$3.19, signaling short‑term bearish pressure. Technical indicators are mixed: RSI sits at 43 (neutral), the MACD histogram has turned positive and the MACD signal is deemed bullish, while volume is on an upward trend, suggesting potential for a near‑term bounce. Fundamentally, the stock appears markedly undervalued with a trailing P/E of 4.79 versus an industry average of 16.35 and a P/B of 0.34, while offering an attractive dividend yield of 6.43% and a modest payout ratio of 31%, indicating dividend sustainability. Analyst consensus is a “hold” with a mean target of HK$3.87, implying roughly 18% upside, and the market sentiment index is in “greed” territory (72.88), reflecting broader optimism.
The bank’s profitability metrics are solid (operating margin 62%, profit margin 44%) despite flat revenue growth (-0.1%) and modest ROE (6.8%). A low beta of 0.14 points to limited market‑wide volatility, although 30‑day price volatility is elevated at ~19% and the historical max drawdown reached -22.7%, flagging price risk. Strong cash reserves (HK$1.04 trn) offset a sizable debt load, and the low valuation coupled with a high dividend makes the stock attractive for value‑oriented investors seeking income and potential upside.
The bank’s profitability metrics are solid (operating margin 62%, profit margin 44%) despite flat revenue growth (-0.1%) and modest ROE (6.8%). A low beta of 0.14 points to limited market‑wide volatility, although 30‑day price volatility is elevated at ~19% and the historical max drawdown reached -22.7%, flagging price risk. Strong cash reserves (HK$1.04 trn) offset a sizable debt load, and the low valuation coupled with a high dividend makes the stock attractive for value‑oriented investors seeking income and potential upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support level of HK$3.19
- Mixed technical signals with bullish MACD but bearish SMA alignment
- High dividend yield providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation gap (P/E 4.79 vs industry 16.35)
- Analyst target price suggesting ~18% upside
- Sustainable dividend supporting total return
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong profitability and cash generation
- Low beta indicating stability in broader market moves
- Consistent dividend policy enhancing long‑term yield
Key Metrics & Analysis
Financial Health
Revenue Growth-10.00%
Profit Margin43.68%
P/E Ratio4.8
ROE6.84%
ROA0.58%
P/B Ratio0.3
Op. Cash FlowHK$25.6B
Industry P/E16.4
Technical Analysis
TrendBearish
RSI43.0
SupportHK$3.19
ResistanceHK$3.49
MA 20HK$3.32
MA 50HK$3.36
MA 200HK$3.57
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target PriceHK$3.87
Upside/Downside18.72%
GradeUndervalued
TypeValue
Dividend Yield6.43%
Risk Assessment
Beta0.14
Volatility18.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.